205 related articles for article (PubMed ID: 15978719)
21. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
Zhang S; Lin QD; DI W
Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
[TBL] [Abstract][Full Text] [Related]
22. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
Mitra SK; Lim ST; Chi A; Schlaepfer DD
Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
[TBL] [Abstract][Full Text] [Related]
23. Cloning and characterization of a novel human BRMS1 transcript variant in hepatocellular carcinoma cells.
Wu J; Wang Y; Qiao X; Saiyin H; Zhao S; Qiao S; Wu Y
Cancer Lett; 2013 Sep; 337(2):266-75. PubMed ID: 23643861
[TBL] [Abstract][Full Text] [Related]
24. COX-2 involvement in breast cancer metastasis to bone.
Singh B; Berry JA; Shoher A; Ayers GD; Wei C; Lucci A
Oncogene; 2007 May; 26(26):3789-96. PubMed ID: 17213821
[TBL] [Abstract][Full Text] [Related]
25. Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer.
Doi H; Shibata MA; Shibata E; Morimoto J; Akao Y; Iinuma M; Tanigawa N; Otsuki Y
Anticancer Res; 2009 Jul; 29(7):2485-95. PubMed ID: 19596918
[TBL] [Abstract][Full Text] [Related]
26. An immunocompetent murine model of metastatic mammary cancer accessible to bioluminescence imaging.
Shibata MA; Shibata E; Morimoto J; Eid NA; Tanaka Y; Watanabe M; Otsuki Y
Anticancer Res; 2009 Nov; 29(11):4389-95. PubMed ID: 20032383
[TBL] [Abstract][Full Text] [Related]
27. A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment.
Wang J; Xia TS; Liu XA; Ding Q; Du Q; Yin H; Wang S
Breast Cancer Res Treat; 2010 Apr; 120(2):337-44. PubMed ID: 19350386
[TBL] [Abstract][Full Text] [Related]
28. The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression.
Hurst DR; Xie Y; Thomas JW; Liu J; Edmonds MD; Stewart MD; Welch DR
PLoS One; 2013; 8(2):e55966. PubMed ID: 23390556
[TBL] [Abstract][Full Text] [Related]
29. Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1.
Rivera J; Megias D; Bravo J
J Proteome Res; 2007 Oct; 6(10):4006-18. PubMed ID: 17854218
[TBL] [Abstract][Full Text] [Related]
30. Lung colonization and metastasis of murine mammary tumors: relationship to various characteristics of the primary tumors.
Basolo F; Toniolo A; Fontanini G; Squartini F
Invasion Metastasis; 1987; 7(5):275-83. PubMed ID: 3679742
[TBL] [Abstract][Full Text] [Related]
31. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
Breast Cancer Res Treat; 2007 Sep; 105(1):29-36. PubMed ID: 17143592
[TBL] [Abstract][Full Text] [Related]
32. Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
Yang L; Huang Y; Porta R; Yanagisawa K; Gonzalez A; Segi E; Johnson DH; Narumiya S; Carbone DP
Cancer Res; 2006 Oct; 66(19):9665-72. PubMed ID: 17018624
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.
Shibata MA; Morimoto J; Shibata E; Otsuki Y
Cancer Gene Ther; 2008 Dec; 15(12):776-86. PubMed ID: 18654613
[TBL] [Abstract][Full Text] [Related]
34. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
35. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
[TBL] [Abstract][Full Text] [Related]
36. Multimodality imaging of IL-18--binding protein-Fc therapy of experimental lung metastasis.
Cao Q; Cai W; Niu G; He L; Chen X
Clin Cancer Res; 2008 Oct; 14(19):6137-45. PubMed ID: 18829492
[TBL] [Abstract][Full Text] [Related]
37. Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation.
Shibata MA; Akao Y; Shibata E; Nozawa Y; Ito T; Mishima S; Morimoto J; Otsuki Y
Cancer Chemother Pharmacol; 2007 Oct; 60(5):681-91. PubMed ID: 17256131
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression.
Yang J; Zhang B; Lin Y; Yang Y; Liu X; Lu F
Cancer Lett; 2008 Sep; 269(1):46-56. PubMed ID: 18502034
[TBL] [Abstract][Full Text] [Related]
39. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.
Croci S; Nicoletti G; Landuzzi L; Palladini A; Chiarini F; Nanni P; Lollini PL; De Giovanni C
Oncol Rep; 2007 Aug; 18(2):451-6. PubMed ID: 17611670
[TBL] [Abstract][Full Text] [Related]
40. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
